Galmed Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell GLMD and other ETFs, options, and stocks.About GLMD
Galmed Pharmaceuticals Ltd. is a clinical-stage drug development biopharmaceutical company, which engages in the development of oral therapy for the treatment of non-alcoholic steato-hepatitis (NASH). Its product candidate, Aramchol, is a synthetic fatty acid-bile acid conjugate molecule for the oral treatment of NASH in patients who are overweight or obese and have prediabetes or type II diabetes mellitus.
CEOAllen Baharaff
CEOAllen Baharaff
Employees6
Employees6
HeadquartersRamat Gan, Tel Aviv
HeadquartersRamat Gan, Tel Aviv
Founded2000
Founded2000
Employees6
Employees6
GLMD Key Statistics
Market cap2.87M
Market cap2.87M
Price-Earnings ratio-0.14
Price-Earnings ratio-0.14
Dividend yield—
Dividend yield—
Average volume3.20M
Average volume3.20M
High today$1.31
High today$1.31
Low today$1.22
Low today$1.22
Open price$1.29
Open price$1.29
Volume113.19K
Volume113.19K
52 Week high$23.80
52 Week high$23.80
52 Week low$1.15
52 Week low$1.15
People also own
Based on the portfolios of people who own GLMD. This list is generated using Robinhood data, and it’s not a recommendation.